S Janssen1, M A M Huson, S Bélard, S Stolp, N Kapata, M Bates, M van Vugt, M P Grobusch. 1. Department of Infectious Diseases, Division of Internal Medicine, Center of Tropical Medicine and Travel Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, P.O. Box 22660, 1100 DD, Amsterdam, The Netherlands.
Abstract
PURPOSE: Reliable and comprehensive data on the HIV/AIDS and TB co-pandemics from Central Africa remain scarce. This systematic review provides a comprehensive overview on current and past research activities in the region and provides a basis for future research work to close knowledge gaps. METHODS: The scientific literature was searched for publications meeting the following search terms: "tuberculosis" or "HIV" or "acquired immunodeficiency syndrome", combined with "Central Africa", or the names of individual countries within the region. Original studies, reviews and case series were included, and a selection of relevant articles was made. RESULTS: Most research in the field of HIV and TB has been conducted in Cameroon, where the epidemics have been described fairly well. The Democratic Republic of Congo ranked second on the amount of publications, despite the civil wars over the past several decades. Very little has been published on HIV and TB in the other countries, possibly due to the poor infrastructure of health care systems, lack of scientific capacity building or shortage of laboratory equipment. CONCLUSIONS: Despite the relatively high burden of HIV and TB in the Central African region, the amount of research activities on these topics is limited. A better understanding of the co-epidemics in this region is urgently needed. The occurrence of opportunistic infections, treatment complications and drug resistance in TB and HIV need to be better described; the failure of public health systems needs to be understood, and research infrastructure needs to be developed. Only then will it be possible to turn the tide against the HIV and TB epidemics in this region.
PURPOSE: Reliable and comprehensive data on the HIV/AIDS and TB co-pandemics from Central Africa remain scarce. This systematic review provides a comprehensive overview on current and past research activities in the region and provides a basis for future research work to close knowledge gaps. METHODS: The scientific literature was searched for publications meeting the following search terms: "tuberculosis" or "HIV" or "acquired immunodeficiency syndrome", combined with "Central Africa", or the names of individual countries within the region. Original studies, reviews and case series were included, and a selection of relevant articles was made. RESULTS: Most research in the field of HIV and TB has been conducted in Cameroon, where the epidemics have been described fairly well. The Democratic Republic of Congo ranked second on the amount of publications, despite the civil wars over the past several decades. Very little has been published on HIV and TB in the other countries, possibly due to the poor infrastructure of health care systems, lack of scientific capacity building or shortage of laboratory equipment. CONCLUSIONS: Despite the relatively high burden of HIV and TB in the Central African region, the amount of research activities on these topics is limited. A better understanding of the co-epidemics in this region is urgently needed. The occurrence of opportunistic infections, treatment complications and drug resistance in TB and HIV need to be better described; the failure of public health systems needs to be understood, and research infrastructure needs to be developed. Only then will it be possible to turn the tide against the HIV and TB epidemics in this region.
Authors: Hélène Péré; Charlotte Charpentier; Pascal Mbelesso; Marius Dandy; Mathieu Matta; Sandrine Moussa; Jean De Dieu Longo; Gérard Grésenguet; Bruno Abraham; Laurent Bélec Journal: AIDS Res Hum Retroviruses Date: 2011-09-23 Impact factor: 2.205
Authors: F Minime-Lingoupou; C Pierre-Audigier; E Kassa-Kélémbho; N Barilone; G Zandanga; J Rauzier; V Cadet-Daniel; A Le Faou; B Gicquel Journal: Int J Tuberc Lung Dis Date: 2010-06 Impact factor: 2.373
Authors: P N Fonjungo; E N Mpoudi; J N Torimiro; G A Alemnji; L T Eno; J N Nkengasong; F Gao; M Rayfield; T M Folks; D Pieniazek; R B Lal Journal: AIDS Res Hum Retroviruses Date: 2000-09-01 Impact factor: 2.205
Authors: Sabine Bélard; Jonathan Remppis; Sanne Bootsma; Saskia Janssen; Davy U Kombila; Justin O Beyeme; Elie G Rossatanga; Cosme Kokou; Kara K Osbak; Régis M Obiang Mba; Harry M Kaba; Afsatou N Traoré; Jonas Ehrhardt; Emmanuel B Bache; Arnaud Flamen; Sabine Rüsch-Gerdes; Matthias Frank; Ayôla A Adegnika; Bertrand Lell; Stefan Niemann; Peter G Kremsner; Marguerite M Loembé; Abraham S Alabi; Martin P Grobusch Journal: Am J Trop Med Hyg Date: 2016-06-27 Impact factor: 2.345
Authors: Michaëla A M Huson; Rachel Kalkman; Sebastiaan M Stolp; Saskia Janssen; Abraham S Alabi; Justin O Beyeme; Tom van der Poll; Martin P Grobusch Journal: Infection Date: 2015-03-11 Impact factor: 3.553
Authors: S Janssen; K Osbak; R Holman; S Hermans; A Moekotte; M Knap; E Rossatanga; M Massinga-Loembe; A Alabi; A Adegnika; C Meenken; M van Vugt; P G Kremsner; G Meintjes; T van der Poll; M P Grobusch Journal: Infection Date: 2017-03-27 Impact factor: 3.553
Authors: Michael Ramharter; Selidji T Agnandji; Ayôla A Adegnika; Bertrand Lell; Ghyslain Mombo-Ngoma; Martin P Grobusch; Matthew McCall; Riko Muranaka; Andrea Kreidenweiss; Thirumalaisamy P Velavan; Meral Esen; Frieder Schaumburg; Abraham Alabi; Christiane Druml; Benjamin Mordmüller; Carsten Köhler; Peter G Kremsner Journal: Wien Klin Wochenschr Date: 2021-01-04 Impact factor: 1.704